<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01614925</url>
  </required_header>
  <id_info>
    <org_study_id>CR 02/11</org_study_id>
    <nct_id>NCT01614925</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain</brief_title>
  <official_title>A Randomized, Controlled, Multicenter Clinical Study Evaluating the Outcomes of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Straumann AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Straumann AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to demonstrate that in supra-alveolar-type defects&#xD;
      (i.e., defects displaying a predominately horizontal pattern of bone loss), periodontal&#xD;
      surgery with the additional use of Straumann® Emdogain will result in significantly higher&#xD;
      Clinical Attachment Level (CAL) gain compared to periodontal surgery without Straumann®&#xD;
      Emdogain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The following secondary endpoints will be evaluated during the study:&#xD;
&#xD;
        -  Change in Gingival Margin (GM) at 12 months after surgery compared to baseline&#xD;
&#xD;
        -  Change in Probing Pocket Depth (PPD) at 12 months after surgery compared to baseline&#xD;
&#xD;
        -  Comparison of early wound healing index (EHI) at 4 weeks after surgery between treatment&#xD;
           groups&#xD;
&#xD;
        -  Comparison of post-surgical pain at 4 weeks after surgery between treatment groups&#xD;
&#xD;
        -  Change in Bleeding on Probing (BoP) at 12 months after surgery compared to baseline&#xD;
&#xD;
        -  Change in root dentin hypersensitivity at 12 months after surgery compared to baseline&#xD;
&#xD;
        -  Change in full mouth plaque index (PI) at 12 months after surgery compared to baseline&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Due to change in strategy and decision not to expand indication.&#xD;
  </why_stopped>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Attachment Level</measure>
    <time_frame>12 Months</time_frame>
    <description>The change in Clinical Attachment Level (CAL) from Baseline to 12 Months. CAL measurements will be derived from the Probing Pocket Depth (PPD) and Gingival Margin (GM) measurements as follows: CAL = PPD - GM.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Gingival Margin (GM) From Baseline to 12 Months</measure>
    <time_frame>12 months after baseline</time_frame>
    <description>GM was measured by recording the distance from the Cemento-Enamel Junction (CEJ) to the margin of the gingiva at 6 sites (mesio-vestibular, mid-vestibular, disto-vestibular, mesio-oral, mid-oral, disto-oral) on the study teeth. Negative value for GM indicates gingival recession. A positive value for the GM indicates the gingiva was covering the CEJ.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Probing Pocket Depth (PPD) From Baseline to 12 Months</measure>
    <time_frame>12 months after baseline</time_frame>
    <description>PPD was measured before the area is anaesthetized by recording the distance from the gingival margin to the bottom of the probable pocket at 6 sites (mesio-vestibular, mid-vestibular, disto-vestibular, mesiooral, mid-oral, and disto-oral) on the study teeth.Negative value for PPD indicates reduction of pocket depth.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early Wound Healing Index (EHI) Assessment at 4 Weeks After Baseline</measure>
    <time_frame>4 weeks after baseline</time_frame>
    <description>Postoperative wound healing was assessed by the EHI according to Wachtel et al. [2003] by visual assessment:&#xD;
complete flap closure - no fibrin line in the interproximal area&#xD;
complete flap closure - fine fibrin line in the interproximal area&#xD;
complete flap closure - fibrin clot in the interproximal area&#xD;
incomplete flap closure - partial necrosis of the interproximal tissue&#xD;
incomplete flap closure - complete necrosis of the interproximal tissue The outcome measure was the percentage of EHI category 1 (complete flap closure - no fibrin line in the interproximal area)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Post-surgical Pain at 4 Weeks After Baseline</measure>
    <time_frame>4 weeks after baseline</time_frame>
    <description>Visual Analog Scale (VAS) for post-surgical pain, minimum value=0, maximum value=10, higher score means worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Bleeding on Probing (BoP) From Baseline to 12 Months</measure>
    <time_frame>12 months after baseline</time_frame>
    <description>The presence of BoP was recorded as a binary response on 6 sites (mesio-vestibular, midvestibular, disto-vestibular, mesio-oral, mid-oral, and disto-oral) on the study teeth. The percentage of positive events per total probing sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in BoP.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Root Dentin Hypersensitivity (RDH) From Baseline to 12 Months</measure>
    <time_frame>12 months after baseline</time_frame>
    <description>RDH was examined by physical testing using cold air as a stimulus. The percentage of positive events per total testing sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in RDH.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Plaque Index (PI) From Baseline to 12 Months</measure>
    <time_frame>12 months after baseline</time_frame>
    <description>The PI was recorded according to O'Leary et al. [1972] as a binary response at the mesial, distal, facial and lingual surfaces on the study teeth. The percentage of positive events per total sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in PI.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Periodontal Attachment Loss</condition>
  <condition>Periodontal Diseases</condition>
  <arm_group>
    <arm_group_label>Emdogain</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Periodontal surgery with the additional use of Straumann® Emdogain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontal Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Periodontal surgery alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Emdogain</intervention_name>
    <description>Periodontal surgery with the additional use of Straumann® Emdogain</description>
    <arm_group_label>Emdogain</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Periodontal surgery</intervention_name>
    <description>Periodontal surgery alone</description>
    <arm_group_label>Periodontal Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects must have advanced periodontitis:&#xD;
&#xD;
          -  presence of supra-alveolar-type defects (i.e., defects displaying a predominantly&#xD;
             horizontal pattern of bone loss) at a minimum of two adjacent teeth and a maximum of 7&#xD;
             adjacent teeth (FDI positions 17-27 or 37-47) in either the maxilla or the mandible&#xD;
             with a PPD of ≥6 mm at a minimum on one site of the examined teeth&#xD;
&#xD;
          -  Teeth must have &lt; Class II mobility&#xD;
&#xD;
          -  Teeth must have horizontal bone loss with an intrabony component of &lt;2 mm as defined&#xD;
             by radiographic evaluation&#xD;
&#xD;
          -  Subjects must have adequate oral hygiene (full mouth plaque index (PI) of &lt;25% at&#xD;
             baseline (i.e., following initial non-surgical periodontal therapy)&#xD;
&#xD;
          -  Subjects must have adequate control of inflammation (full mouth bleeding on probing&#xD;
             (FMBP) of &lt;25% at baseline (i.e., following initial non-surgical periodontal therapy)&#xD;
&#xD;
          -  Subjects must have voluntarily signed the informed consent form before any study&#xD;
             related procedures&#xD;
&#xD;
          -  Subjects must be males and females of at least 18 years of age&#xD;
&#xD;
          -  Subjects must be committed to the study and the required follow-up visits&#xD;
&#xD;
          -  Subjects must be in good general health as assessed by the investigator at time of&#xD;
             surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Pre-surgical exclusion criteria:&#xD;
&#xD;
          -  Subjects with any contraindications for oral surgical procedures&#xD;
&#xD;
          -  Subjects with uncontrolled diabetes or other uncontrolled systemic diseases&#xD;
&#xD;
          -  Subjects with disorders or treatments that compromise wound healing&#xD;
&#xD;
          -  Subjects with medical conditions requiring chronic high dose steroid therapy&#xD;
&#xD;
          -  Subjects with bone metabolic diseases&#xD;
&#xD;
          -  Subjects with radiation or other immuno-oppressive therapy&#xD;
&#xD;
          -  Subjects with infections or vascular impairment at the surgical site&#xD;
&#xD;
          -  Subjects who are on antibiotic treatment or chronic anti-inflammatory treatment (≥3&#xD;
             times per week) within 4 weeks prior to surgery.&#xD;
&#xD;
          -  Subjects with the presence of oral lesions (such as ulceration, malignancy)&#xD;
&#xD;
          -  Subjects with mucosal diseases (e.g., lichen planus, mouth ulcer)&#xD;
&#xD;
          -  Subjects with a history of malignant disease in the oral cavity or previous&#xD;
             radiotherapy to the head or neck&#xD;
&#xD;
          -  Subjects with inadequate oral hygiene or unmotivated for adequate home care&#xD;
&#xD;
          -  Subjects that have been treated with an investigational drug or device within the 30&#xD;
             day period immediately prior to surgery on study day 0.&#xD;
&#xD;
          -  Subjects who currently smoke&#xD;
&#xD;
          -  Female subjects who are nursing, pregnant, or plan to become pregnant&#xD;
&#xD;
        Secondary exclusion criteria:&#xD;
&#xD;
          -  Subjects with an osseous defect with an intrabony component of ≥2 mm or involving&#xD;
             furcation involvement ≥ class II at the tooth of interest&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 6, 2012</study_first_submitted>
  <study_first_submitted_qc>June 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2012</study_first_posted>
  <results_first_submitted>August 18, 2020</results_first_submitted>
  <results_first_submitted_qc>November 5, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 1, 2020</results_first_posted>
  <last_update_submitted>November 5, 2020</last_update_submitted>
  <last_update_submitted_qc>November 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Periodontal Attachment Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The recruitment was terminated prematurely.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Emdogain</title>
          <description>Periodontal surgery with the additional use of Straumann® Emdogain&#xD;
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain</description>
        </group>
        <group group_id="P2">
          <title>Periodontal Surgery</title>
          <description>Periodontal surgery alone&#xD;
Periodontal surgery: Periodontal surgery alone</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Emdogain</title>
          <description>Periodontal surgery with the additional use of Straumann® Emdogain&#xD;
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain</description>
        </group>
        <group group_id="B2">
          <title>Periodontal Surgery</title>
          <description>Periodontal surgery alone&#xD;
Periodontal surgery: Periodontal surgery alone</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="18"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="35"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.3" spread="14.0"/>
                    <measurement group_id="B2" value="53.9" spread="13.2"/>
                    <measurement group_id="B3" value="52.4" spread="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Clinical Attachment Level</title>
        <description>The change in Clinical Attachment Level (CAL) from Baseline to 12 Months. CAL measurements will be derived from the Probing Pocket Depth (PPD) and Gingival Margin (GM) measurements as follows: CAL = PPD - GM.</description>
        <time_frame>12 Months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain</title>
            <description>Periodontal surgery with the additional use of Straumann® Emdogain&#xD;
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain</description>
          </group>
          <group group_id="O2">
            <title>Periodontal Surgery</title>
            <description>Periodontal surgery alone&#xD;
Periodontal surgery: Periodontal surgery alone</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Attachment Level</title>
          <description>The change in Clinical Attachment Level (CAL) from Baseline to 12 Months. CAL measurements will be derived from the Probing Pocket Depth (PPD) and Gingival Margin (GM) measurements as follows: CAL = PPD - GM.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.91" spread="1.3"/>
                    <measurement group_id="O2" value="-2.08" spread="1.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Gingival Margin (GM) From Baseline to 12 Months</title>
        <description>GM was measured by recording the distance from the Cemento-Enamel Junction (CEJ) to the margin of the gingiva at 6 sites (mesio-vestibular, mid-vestibular, disto-vestibular, mesio-oral, mid-oral, disto-oral) on the study teeth. Negative value for GM indicates gingival recession. A positive value for the GM indicates the gingiva was covering the CEJ.</description>
        <time_frame>12 months after baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain</title>
            <description>Periodontal surgery with the additional use of Straumann® Emdogain&#xD;
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain</description>
          </group>
          <group group_id="O2">
            <title>Periodontal Surgery</title>
            <description>Periodontal surgery alone&#xD;
Periodontal surgery: Periodontal surgery alone</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Gingival Margin (GM) From Baseline to 12 Months</title>
          <description>GM was measured by recording the distance from the Cemento-Enamel Junction (CEJ) to the margin of the gingiva at 6 sites (mesio-vestibular, mid-vestibular, disto-vestibular, mesio-oral, mid-oral, disto-oral) on the study teeth. Negative value for GM indicates gingival recession. A positive value for the GM indicates the gingiva was covering the CEJ.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.36" spread="0.84"/>
                    <measurement group_id="O2" value="-0.27" spread="1.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Probing Pocket Depth (PPD) From Baseline to 12 Months</title>
        <description>PPD was measured before the area is anaesthetized by recording the distance from the gingival margin to the bottom of the probable pocket at 6 sites (mesio-vestibular, mid-vestibular, disto-vestibular, mesiooral, mid-oral, and disto-oral) on the study teeth.Negative value for PPD indicates reduction of pocket depth.</description>
        <time_frame>12 months after baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain</title>
            <description>Periodontal surgery with the additional use of Straumann® Emdogain&#xD;
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain</description>
          </group>
          <group group_id="O2">
            <title>Periodontal Surgery</title>
            <description>Periodontal surgery alone&#xD;
Periodontal surgery: Periodontal surgery alone</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Probing Pocket Depth (PPD) From Baseline to 12 Months</title>
          <description>PPD was measured before the area is anaesthetized by recording the distance from the gingival margin to the bottom of the probable pocket at 6 sites (mesio-vestibular, mid-vestibular, disto-vestibular, mesiooral, mid-oral, and disto-oral) on the study teeth.Negative value for PPD indicates reduction of pocket depth.</description>
          <units>mm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.93" spread="1.44"/>
                    <measurement group_id="O2" value="-2.47" spread="1.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Early Wound Healing Index (EHI) Assessment at 4 Weeks After Baseline</title>
        <description>Postoperative wound healing was assessed by the EHI according to Wachtel et al. [2003] by visual assessment:&#xD;
complete flap closure - no fibrin line in the interproximal area&#xD;
complete flap closure - fine fibrin line in the interproximal area&#xD;
complete flap closure - fibrin clot in the interproximal area&#xD;
incomplete flap closure - partial necrosis of the interproximal tissue&#xD;
incomplete flap closure - complete necrosis of the interproximal tissue The outcome measure was the percentage of EHI category 1 (complete flap closure - no fibrin line in the interproximal area)</description>
        <time_frame>4 weeks after baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain</title>
            <description>Periodontal surgery with the additional use of Straumann® Emdogain&#xD;
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain</description>
          </group>
          <group group_id="O2">
            <title>Periodontal Surgery</title>
            <description>Periodontal surgery alone&#xD;
Periodontal surgery: Periodontal surgery alone</description>
          </group>
        </group_list>
        <measure>
          <title>Early Wound Healing Index (EHI) Assessment at 4 Weeks After Baseline</title>
          <description>Postoperative wound healing was assessed by the EHI according to Wachtel et al. [2003] by visual assessment:&#xD;
complete flap closure - no fibrin line in the interproximal area&#xD;
complete flap closure - fine fibrin line in the interproximal area&#xD;
complete flap closure - fibrin clot in the interproximal area&#xD;
incomplete flap closure - partial necrosis of the interproximal tissue&#xD;
incomplete flap closure - complete necrosis of the interproximal tissue The outcome measure was the percentage of EHI category 1 (complete flap closure - no fibrin line in the interproximal area)</description>
          <units>percentage of EHI category 1</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93"/>
                    <measurement group_id="O2" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Comparison of Post-surgical Pain at 4 Weeks After Baseline</title>
        <description>Visual Analog Scale (VAS) for post-surgical pain, minimum value=0, maximum value=10, higher score means worse outcome</description>
        <time_frame>4 weeks after baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain</title>
            <description>Periodontal surgery with the additional use of Straumann® Emdogain&#xD;
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain</description>
          </group>
          <group group_id="O2">
            <title>Periodontal Surgery</title>
            <description>Periodontal surgery alone&#xD;
Periodontal surgery: Periodontal surgery alone</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison of Post-surgical Pain at 4 Weeks After Baseline</title>
          <description>Visual Analog Scale (VAS) for post-surgical pain, minimum value=0, maximum value=10, higher score means worse outcome</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.21" spread="9.39"/>
                    <measurement group_id="O2" value="3.47" spread="7.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Bleeding on Probing (BoP) From Baseline to 12 Months</title>
        <description>The presence of BoP was recorded as a binary response on 6 sites (mesio-vestibular, midvestibular, disto-vestibular, mesio-oral, mid-oral, and disto-oral) on the study teeth. The percentage of positive events per total probing sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in BoP.</description>
        <time_frame>12 months after baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain</title>
            <description>Periodontal surgery with the additional use of Straumann® Emdogain&#xD;
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain</description>
          </group>
          <group group_id="O2">
            <title>Periodontal Surgery</title>
            <description>Periodontal surgery alone&#xD;
Periodontal surgery: Periodontal surgery alone</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Bleeding on Probing (BoP) From Baseline to 12 Months</title>
          <description>The presence of BoP was recorded as a binary response on 6 sites (mesio-vestibular, midvestibular, disto-vestibular, mesio-oral, mid-oral, and disto-oral) on the study teeth. The percentage of positive events per total probing sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in BoP.</description>
          <units>percentage of BoP change</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-36"/>
                    <measurement group_id="O2" value="-13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Root Dentin Hypersensitivity (RDH) From Baseline to 12 Months</title>
        <description>RDH was examined by physical testing using cold air as a stimulus. The percentage of positive events per total testing sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in RDH.</description>
        <time_frame>12 months after baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain</title>
            <description>Periodontal surgery with the additional use of Straumann® Emdogain&#xD;
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain</description>
          </group>
          <group group_id="O2">
            <title>Periodontal Surgery</title>
            <description>Periodontal surgery alone&#xD;
Periodontal surgery: Periodontal surgery alone</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Root Dentin Hypersensitivity (RDH) From Baseline to 12 Months</title>
          <description>RDH was examined by physical testing using cold air as a stimulus. The percentage of positive events per total testing sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in RDH.</description>
          <units>percentage of RDH change</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-21.4"/>
                    <measurement group_id="O2" value="-26.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Plaque Index (PI) From Baseline to 12 Months</title>
        <description>The PI was recorded according to O'Leary et al. [1972] as a binary response at the mesial, distal, facial and lingual surfaces on the study teeth. The percentage of positive events per total sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in PI.</description>
        <time_frame>12 months after baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Emdogain</title>
            <description>Periodontal surgery with the additional use of Straumann® Emdogain&#xD;
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain</description>
          </group>
          <group group_id="O2">
            <title>Periodontal Surgery</title>
            <description>Periodontal surgery alone&#xD;
Periodontal surgery: Periodontal surgery alone</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Plaque Index (PI) From Baseline to 12 Months</title>
          <description>The PI was recorded according to O'Leary et al. [1972] as a binary response at the mesial, distal, facial and lingual surfaces on the study teeth. The percentage of positive events per total sites was calculated for each group. The outcome measure was the change between baseline and 12 months. Negative values indicate a decrease in PI.</description>
          <units>percentage of PI change</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.7"/>
                    <measurement group_id="O2" value="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Emdogain</title>
          <description>Periodontal surgery with the additional use of Straumann® Emdogain&#xD;
Emdogain: Periodontal surgery with the additional use of Straumann® Emdogain</description>
        </group>
        <group group_id="E2">
          <title>Periodontal Surgery</title>
          <description>Periodontal surgery alone&#xD;
Periodontal surgery: Periodontal surgery alone</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Tooth hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Aphthous ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Early termination leading to small numbers of subjects analyzed. This sponsor decision was based on commercial reasons and not linked to any safety concerns or new scientific knowledge.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Michel Mallaun</name_or_title>
      <organization>Straumann</organization>
      <email>michel.mallaun@straumann.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

